Understanding bsAb Liabilities and Their Impact on Development Risk: A Webinar by Xtalks
In the world of biopharmaceutical development, the ability to predict and manage potential liabilities associated with bispecific antibodies (bsAbs) is critical. Understanding parental Fab liabilities can play a significant role in determining the success of final bispecific assemblies. Fortunately, Xtalks is offering an informative free webinar on this very topic: ‘Predict bsAb Liabilities Earlier to Reduce Development Risk.’ The session, scheduled for July 20, 2026, aims to enlighten attendees on how bsAb developability data can be instrumental in recognizing pairing risks and identifying emerging liabilities that could compromise complex biologics early in the development process.
Ammar Arsiwala, Director of Antibody Developability at Ginkgo Datapoints, will be leading this insightful session. During the webinar, he will explain the ‘Rule of Additivity’ and its role in understanding how certain parental antibodies' attributes impact bsAb assemblies. This rule helps clarify which properties are carried over from parental antibodies to their bispecific counterparts, while also exposing the limitations where these predictions fail. Through the presentation of empirical data derived from a systematic 160-member bispecific library, insights will be shared regarding the reliability of parental screening and the characteristics that are likely to cause risks during the assembly of bsAbs.
Beyond the theoretical aspects, attendees will gain valuable information on how systematic developability data can be employed to predict pairings effectively, highlighting risks and paving pathways to de-risk biologics. Issues related to linear additivity will be addressed, offering a deeper understanding of emergent liabilities that may not align with preformulated predictions. This knowledge is vital for professionals in the pharmaceutical and biotechnology sectors, allowing for a proactive approach to managing risks associated with drug development.
Register now for the chance to equip yourself with crucial knowledge that can streamline your development process and facilitate better decision-making as you navigate the complexities of biopharmaceutical innovation. Whether you're a researcher, a project manager, or part of a regulatory body, this webinar promises to provide actionable insights into the intricate dynamics of bispecific antibody development. Join us and learn how to position your project for success by effectively managing pairings and liabilities.
To find out more or to reserve your spot in this compelling event, visit the registration page linked in the webinar announcement. Xtalks is committed to equipping professionals in the life sciences community with the essential tools and information needed to thrive in a fast-evolving industry. Embrace the opportunity to stay ahead of the curve and gain insights from industry leaders to enhance your strategic approach to drug development. Don’t miss out—secure your participation today!
Xtalks is a premier life science platform designed to support professionals across various sectors, including pharma, biotech, and healthcare. With an extensive array of resources that encompass articles, webinars, interviews, videos, and job opportunities, Xtalks serves as a vibrant community where industry professionals can connect, engage, and enhance their knowledge. Powered by Honeycomb Worldwide Inc., the platform has become a trusted source for timely intelligence and collaborative insights, fostering informed decision-making in the life sciences.
The upcoming webinar on bsAb liabilities is not just an opportunity to learn but also a chance to interact with experts and peers in the industry. It emphasizes the importance of proactive risk management in drug development, setting the stage for innovation and continued progress in the field. Ensure you're equipped with the knowledge necessary for the next wave of advancements in biotechnology by attending this essential session.
Ammar Arsiwala, Director of Antibody Developability at Ginkgo Datapoints, will be leading this insightful session. During the webinar, he will explain the ‘Rule of Additivity’ and its role in understanding how certain parental antibodies' attributes impact bsAb assemblies. This rule helps clarify which properties are carried over from parental antibodies to their bispecific counterparts, while also exposing the limitations where these predictions fail. Through the presentation of empirical data derived from a systematic 160-member bispecific library, insights will be shared regarding the reliability of parental screening and the characteristics that are likely to cause risks during the assembly of bsAbs.
Beyond the theoretical aspects, attendees will gain valuable information on how systematic developability data can be employed to predict pairings effectively, highlighting risks and paving pathways to de-risk biologics. Issues related to linear additivity will be addressed, offering a deeper understanding of emergent liabilities that may not align with preformulated predictions. This knowledge is vital for professionals in the pharmaceutical and biotechnology sectors, allowing for a proactive approach to managing risks associated with drug development.
Register now for the chance to equip yourself with crucial knowledge that can streamline your development process and facilitate better decision-making as you navigate the complexities of biopharmaceutical innovation. Whether you're a researcher, a project manager, or part of a regulatory body, this webinar promises to provide actionable insights into the intricate dynamics of bispecific antibody development. Join us and learn how to position your project for success by effectively managing pairings and liabilities.
To find out more or to reserve your spot in this compelling event, visit the registration page linked in the webinar announcement. Xtalks is committed to equipping professionals in the life sciences community with the essential tools and information needed to thrive in a fast-evolving industry. Embrace the opportunity to stay ahead of the curve and gain insights from industry leaders to enhance your strategic approach to drug development. Don’t miss out—secure your participation today!
About Xtalks
Xtalks is a premier life science platform designed to support professionals across various sectors, including pharma, biotech, and healthcare. With an extensive array of resources that encompass articles, webinars, interviews, videos, and job opportunities, Xtalks serves as a vibrant community where industry professionals can connect, engage, and enhance their knowledge. Powered by Honeycomb Worldwide Inc., the platform has become a trusted source for timely intelligence and collaborative insights, fostering informed decision-making in the life sciences.
Conclusion
The upcoming webinar on bsAb liabilities is not just an opportunity to learn but also a chance to interact with experts and peers in the industry. It emphasizes the importance of proactive risk management in drug development, setting the stage for innovation and continued progress in the field. Ensure you're equipped with the knowledge necessary for the next wave of advancements in biotechnology by attending this essential session.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.